Hong Kong stock market anomaly | Meinian Health (02291.HK) rose by more than 12%, breaking through the global development process of self-developed MemoSorb. Recently, the first planting has been completed in Italy and three other countries.
According to the China Fortune Financial App, Sinocare Medical (02291.HK) has risen by over 12%, as of the time of writing, it is up 12.21% at HK$10.54, with a trading volume of HK$1.58 billion.
Latest
